Barclays PLC Cumberland Pharmaceuticals Inc Transaction History

Barclays PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$3.14 - $3.48 $69 - $76	-22 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$3.17 - $4.01 $69 - $88	22 New	22 $0
Q1 2020 May 13, 2020	SELL	$3.45 - $5.33 $10 - $15	-3 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$4.68 - $5.79 $383 - $474	-82 Reduced 96.47%	3 $0
Q3 2019 Nov 14, 2019	BUY	$4.73 - $6.4 $402 - $544	85 New	85 $1,000

1.97M

44.2K

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $20.1M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.